Yeah. Personally, I've experienced the risk of suicidal behavior when starting a drug - Cymbalta - and also when it was reduced. When I started it, I attempted suicide because it affected implusiveness - but the suicidal ideation was already present. That event was the result of poor accountability at such a risky point in treatment. The attempt when it was reduced was obvious enough, I crashed because I was no longer getting the thing that was helping me. At both times in treatment a patient should be closely monitored - the medications themselves advise this, citing the risks I'm describing. The fear from the media is ludicrious; they ought to only be providing warnings to monitor patients - especially adolescents - when changing medicine.